News - Cardio-vascular, Omthera Pharmaceuticals


Popular Filters

Amarin files suit against AstraZeneca over Epanova

Amarin files suit against AstraZeneca over Epanova


US biotech firm Amarin revealed in a Stock Exchange Commission submission that it has filed a complaint…

AmarinAstraZenecaBiotechnologyCardio-vascularEpanovaLegalNorth AmericaOmthera PharmaceuticalsPatentsUSAVascepa

US FDA accepts Epanova NDA filing


Anglo-Swedish drug major AstraZeneca (LSE: AZN) today announced that the US Food and Drug Administration…

AstraZenecaCardio-vascularEpanovaNorth AmericaOmthera PharmaceuticalsPharmaceuticalRegulation

AstraZeneca target Omthera files for US approval of Epanova


Emerging US specialty pharmaceutical company Omthera Pharmaceuticals (Nasdaq: OMTH) today (July 9) announced…

AstraZenecaCardio-vascularCrestorEpanovaOmthera PharmaceuticalsPharmaceutical

AstraZeneca to buy Omthera in up to $443 million deal


Anglo-Swedish drug major AstraZeneca's (LSE: AZN) new chief executive Pascal Soriot is making another…

AstraZenecaCardio-vascularEpanovaMergers & AcquisitionsOmthera PharmaceuticalsPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top